MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1
Inhibitors of MET have not produced satisfactory outcomes in trials of patients with liver cancer. We investigated the mechanisms of liver tumor resistance to MET inhibitors in mice. We tested the effects of MET inhibitors tivantinib and capmatinib in the mouse hepatocellular carcinoma (HCC) cell li...
Saved in:
| Published in: | Gastroenterology (New York, N.Y. 1943) Vol. 156; no. 6; p. 1849 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01.05.2019
|
| Subjects: | |
| ISSN: | 1528-0012, 1528-0012 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!